11/19/2024China Grants Priority Review to Ascentage Pharma's Lisaftoclax NDA

11/18/2024ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...

11/18/2024FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...

11/18/2024Rona Therapeutics Unveils Promising Phase 1 Results for RNA-Based Chol...

11/18/2024Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...

11/14/2024Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...

11/13/2024Novartis Files NDA of Pluvicto (Lu 177 vipivotide tetraxetan) in China

11/13/2024NMPA Accepts CANbridge Pharma's NDA of CAN103 for Gaucher Disease

11/12/2024Eccogene Secures Dual IND Approvals for Once-Daily Oral GLP-1 Receptor...

11/12/2024CStone Presents Promising Preclinical Data for Trispecific Antibody CS...

11/12/2024Abbisco Reports Positive Top-line Results from Pivotal Phase 3 MANEUVE...

11/11/2024Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC Tre...

11/11/2024China Approves Second KRAS-G12C Inhibitor, Garsorasib, Co-developed by...

11/11/2024Precision Bio's CD19-Targeted CAR-T Therapy, pCAR-19B, Selected for Or...

11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...

11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...

11/8/2024Takeda Initiates Phase 3 Trials in China for Sleep Disorder Drug TAK-8...

11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...

11/7/2024AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designation...

11/7/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...

11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA

11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses

10/31/2024CirCode Advances Gene Therapy with HM2002 IND Approval

10/31/2024AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA

Page:16/18 Total number of articles:534: [First][<<] [14] [15] [16] [17] [18] [>>] [End]